• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Developing drugs targeting CX3CL1 to treat heart diseases via immune/inflammatory mediation.

作者信息

Zou Lin, Ma Junhua, Hu Guiying, Zhu Hongling, Zhang Lijuan, Li Xiangqi

机构信息

Department of Endocrinology and Metabolism, Gongli Hospital, Naval Medical University, Shanghai 200135, China.

Outpatient Department, Zhongxian People's Hospital, Chongqing 404300, China.

出版信息

Acta Biochim Biophys Sin (Shanghai). 2023 Oct 25;55(10):1672-1676. doi: 10.3724/abbs.2023157.

DOI:10.3724/abbs.2023157
PMID:37580951
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10577471/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/927b/10577471/49dc5972d80e/ABBS-2023-332-t2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/927b/10577471/164198f25aed/ABBS-2023-332-t1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/927b/10577471/49dc5972d80e/ABBS-2023-332-t2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/927b/10577471/164198f25aed/ABBS-2023-332-t1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/927b/10577471/49dc5972d80e/ABBS-2023-332-t2.jpg

相似文献

1
Developing drugs targeting CX3CL1 to treat heart diseases via immune/inflammatory mediation.开发靶向CX3CL1的药物，通过免疫/炎症介导来治疗心脏病。
Acta Biochim Biophys Sin (Shanghai). 2023 Oct 25;55(10):1672-1676. doi: 10.3724/abbs.2023157.
2
[Research advances in the role of CX3CL1 and its receptor in liver diseases].
Zhonghua Gan Zang Bing Za Zhi. 2016 Apr;24(4):313-6. doi: 10.3760/cma.j.issn.1007-3418.2016.04.016.
3
CX3CL1 Signaling in the Tumor Microenvironment.CX3CL1 信号在肿瘤微环境中的作用。
Adv Exp Med Biol. 2020;1231:1-12. doi: 10.1007/978-3-030-36667-4_1.
4
Role of CX3CL1/CX3CR1 Signaling Axis Activity in Osteoporosis.CX3CL1/CX3CR1 信号轴活性在骨质疏松症中的作用。
Mediators Inflamm. 2019 Nov 12;2019:7570452. doi: 10.1155/2019/7570452. eCollection 2019.
5
The chemokine CX3CL1 (fractalkine) and its receptor CX3CR1: occurrence and potential role in osteoarthritis.趋化因子CX3CL1（fractalkine）及其受体CX3CR1：在骨关节炎中的存在情况及潜在作用
Arch Immunol Ther Exp (Warsz). 2014 Oct;62(5):395-403. doi: 10.1007/s00005-014-0275-0. Epub 2014 Feb 21.
6
Role of the CXCL1-CXCR1 axis in renal disease.CXCL1-CXCR1 轴在肾脏疾病中的作用。
Am J Physiol Renal Physiol. 2021 Aug 1;321(2):F121-F134. doi: 10.1152/ajprenal.00059.2021. Epub 2021 Jun 14.
7
Pathophysiological Roles of the CX3CL1-CX3CR1 Axis in Renal Disease, Cardiovascular Disease, and Cancer.CX3CL1-CX3CR1轴在肾脏疾病、心血管疾病和癌症中的病理生理作用
Int J Mol Sci. 2025 Jun 3;26(11):5352. doi: 10.3390/ijms26115352.
8
Fractalkine (CX3CL1) and Its Receptor CX3CR1: A Promising Therapeutic Target in Chronic Kidney Disease? fractalkine (CX3CL1)及其受体 CX3CR1：慢性肾脏病的有前途的治疗靶点？
Front Immunol. 2021 Jun 7;12:664202. doi: 10.3389/fimmu.2021.664202. eCollection 2021.
9
CX3C chemokine: Hallmarks of fibrosis and ageing.CX3C 趋化因子：纤维化和衰老的特征。
Pharmacol Res. 2024 Oct;208:107348. doi: 10.1016/j.phrs.2024.107348. Epub 2024 Aug 10.
10
CX3CL1 expression in the conjunctiva is involved in immune cell trafficking during toxic ocular surface inflammation.CX3CL1 在结膜中的表达参与了毒性眼表炎症期间免疫细胞的迁移。
Mucosal Immunol. 2012 Nov;5(6):702-11. doi: 10.1038/mi.2012.43. Epub 2012 Jun 13.

本文引用的文献

1
Potential of ATP5MG to Treat Metabolic Syndrome-Associated Cardiovascular Diseases.ATP5MG治疗代谢综合征相关心血管疾病的潜力。
Front Cardiovasc Med. 2022 Jul 22;9:921778. doi: 10.3389/fcvm.2022.921778. eCollection 2022.
2
New values of a type 2 taste receptor TAS2R14 in thyroid cancer.2型味觉受体TAS2R14在甲状腺癌中的新价值。
Acta Biochim Biophys Sin (Shanghai). 2022 Apr 25;54(4):587-589. doi: 10.3724/abbs.2022026.
3
Asymptomatic Transmissibility Calls for Implementing a Zero-COVID Strategy to End the Current Global Crisis.
无症状传播呼吁实施零新冠病毒战略以结束当前的全球危机。
Front Cell Infect Microbiol. 2022 Apr 19;12:836409. doi: 10.3389/fcimb.2022.836409. eCollection 2022.
4
Historic opportunity: artificial intelligence interventions in COVID-19 and other unknown diseases.历史性机遇：人工智能在新冠疫情及其他未知疾病中的干预措施
Acta Biochim Biophys Sin (Shanghai). 2021 Nov 10;53(11):1575-1577. doi: 10.1093/abbs/gmab120.
5
K-SEIR-Sim: A simple customized software for simulating the spread of infectious diseases.K-SEIR-Sim：一款用于模拟传染病传播的简单定制软件。
Comput Struct Biotechnol J. 2021;19:1966-1975. doi: 10.1016/j.csbj.2021.04.004. Epub 2021 Apr 7.
6
Rediscovery of Caffeine: An Excellent Drug for Improving Patient Outcomes while Fighting WARS.重新发现咖啡因：一种既能改善患者预后，又能对抗战争的绝佳药物。
Curr Med Chem. 2021;28(27):5449-5462. doi: 10.2174/0929867327666201103162810.
7
Heart failure in COVID-19 patients: prevalence, incidence and prognostic implications.新型冠状病毒肺炎患者的心衰：患病率、发病率和预后意义。
Eur J Heart Fail. 2020 Dec;22(12):2205-2215. doi: 10.1002/ejhf.1990. Epub 2020 Oct 7.
8
Existing bitter medicines for fighting 2019-nCoV-associated infectious diseases.治疗 2019-nCoV 相关传染病的现有苦味药物。
FASEB J. 2020 May;34(5):6008-6016. doi: 10.1096/fj.202000502. Epub 2020 Apr 13.
9
Bitter receptor member TAS2R4 may have neurobiological function beyond acting as a bitter receptor.
Acta Biochim Biophys Sin (Shanghai). 2020 Apr 20;52(4):460-462. doi: 10.1093/abbs/gmaa003.
10
Systematic prediction of the biological functions of TAS2R10 using positive co-expression analysis.使用正向共表达分析对TAS2R10的生物学功能进行系统预测。
Exp Ther Med. 2020 Mar;19(3):1733-1738. doi: 10.3892/etm.2019.8397. Epub 2019 Dec 31.